Cargando…

Targeting SIRT1 to inhibit the proliferation of multiple myeloma cells

Multiple myeloma (MM) is the second most common hematopoietic malignancy and remains an incurable disease. Thus, novel drugs and therapeutic methods are required for patients with MM. The present study aimed to investigate the effect of sirtuin 1 (SIRT1) inhibitor cambinol on the proliferation and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Bo, Zhang, Dengyang, Wang, Xiaobo, Lin, Dongjun, Chen, Yun, Xu, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905587/ https://www.ncbi.nlm.nih.gov/pubmed/33732382 http://dx.doi.org/10.3892/ol.2021.12567

Ejemplares similares

Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
por: Zhao, Yuming, et al.
Publicado: (2021)

miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1
por: Li, Chuntao, et al.
Publicado: (2016)

Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle
por: Wang, Xiaobo, et al.
Publicado: (2023)

KDM2A Targets PFKFB3 for Ubiquitylation to Inhibit the Proliferation and Angiogenesis of Multiple Myeloma Cells
por: Liu, Xinling, et al.
Publicado: (2021)

miR-140-5p inhibits the proliferation of multiple myeloma cells by targeting VEGFA
por: Liu, Min, et al.
Publicado: (2021)

MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1
por: Ying, Shi, et al.
Publicado: (2017)

MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis
por: Che, Feifei, et al.
Publicado: (2020)

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
por: Steiro, Ida, et al.
Publicado: (2022)

Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma
por: Guo, Mengjie, et al.
Publicado: (2021)

Inhibition of Proliferation and Induction of Apoptosis in Multiple Myeloma Cell Lines by CD137 Ligand Signaling
por: Gullo, Charles, et al.
Publicado: (2010)

PDK1 inhibition is a novel therapeutic target in multiple myeloma
por: Fujiwara, S, et al.
Publicado: (2013)

Resveratrol inhibits adventitial fibroblast proliferation and induces cell apoptosis through the SIRT1 pathway
por: Ling, Lin, et al.
Publicado: (2017)

Inhibition of CARM1 suppresses proliferation of multiple myeloma cells through activation of p53 signaling pathway
por: Yang, Lan, et al.
Publicado: (2023)

Retraction: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis
Publicado: (2021)

EGCG Inhibits Proliferation and Induces Apoptosis Through Downregulation of SIRT1 in Nasopharyngeal Carcinoma Cells
por: Jiang, Shisheng, et al.
Publicado: (2022)

Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma
por: Li, Anmao, et al.
Publicado: (2020)

BCMA-targeted immunotherapy for multiple myeloma
por: Yu, Bo, et al.
Publicado: (2020)

Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling
por: Heo, Sook-Kyoung, et al.
Publicado: (2022)

Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest
por: Hu, Yiwang, et al.
Publicado: (2019)

SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism
por: Chen, Zhouxun, et al.
Publicado: (2019)

MicroRNA-338-3p Inhibits Proliferation and Promotes Apoptosis of Multiple Myeloma Cells Through Targeting Cyclin-Dependent Kinase 4
por: Cao, Yang, et al.
Publicado: (2018)

Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells
por: Heinemann, Luca, et al.
Publicado: (2022)

SIRT1 promotes pulmonary artery endothelial cell proliferation by targeting the Akt signaling pathway
por: Xi, Liandong, et al.
Publicado: (2020)

SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity
por: Feng, Xiaojun, et al.
Publicado: (2020)

Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90
por: Zhao, Ming, et al.
Publicado: (2011)

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells
por: Ohanna, Mickaël, et al.
Publicado: (2014)

Carfilzomib inhibits the proliferation and apoptosis of multiple myeloma cells by inhibiting STAT1/COX-2/iNOS signaling pathway
por: He, Shaolong, et al.
Publicado: (2022)

Knockdown of DNA methyltransferase-1 inhibits proliferation and derepresses tumor suppressor genes in myeloma cells
por: ZHOU, WENWEN, et al.
Publicado: (2014)

DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling
por: Ishiguro, Kazuya, et al.
Publicado: (2019)

Cancerous Inhibitor of PP2A Silencing Inhibits Proliferation and Promotes Apoptosis in Human Multiple Myeloma Cells
por: Yang, Xi, et al.
Publicado: (2016)

BIBR1532 inhibits proliferation and enhances apoptosis in multiple myeloma cells by reducing telomerase activity
por: Zhang, Yuefeng, et al.
Publicado: (2023)

Sirt1 Antisense Long Noncoding RNA Promotes Cardiomyocyte Proliferation by Enhancing the Stability of Sirt1
por: Li, Bing, et al.
Publicado: (2018)

Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma
por: Peng, Huiming, et al.
Publicado: (2011)

Osteogenic Inhibition in Multiple Myeloma
por: Habibi, Hussain, et al.
Publicado: (2013)

Suppressive effect of microRNA-138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1
por: Yuan, Zhenchao, et al.
Publicado: (2017)

AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2022)

miR-22 inhibits mouse ovarian granulosa cell apoptosis by targeting SIRT1
por: Xiong, Fang, et al.
Publicado: (2016)

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma
por: Gelli, Elisa, et al.
Publicado: (2023)

SIRT1 and SIRT2: emerging targets in neurodegeneration
por: Donmez, Gizem, et al.
Publicado: (2013)

BRCA1 inhibits AR–mediated proliferation of breast cancer cells through the activation of SIRT1
por: Zhang, Wenwen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0e5l95kt1p4nbaq6gobgfhpcso